secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001493152-24-029243
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals shareholders approve 15x increase in authorized common stock to 250M shares
--------------------------------------------------------------------------------

- Authorized common shares increased from 16,666,666 to 250,000,000; amendment filed July 25, 2024.
- Shareholders also approved issuance of shares underlying Series F-1 and G Preferred and warrants for Nasdaq Rule 5635 compliance.
- Share Increase Proposal vote: 819,760 for, 73,259 against, 12,851 abstain.
- Ratification of Morison Cogen as independent auditor for FY2024 passed with 1,536,758 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/0001493152-24-029243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224029243/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer